Mapk
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Mapk is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Bisphenol A promotes colorectal cancer malignancy through CXCL8 upregulation associated with p38 MAPK activation: A potential link to type 2 diabetes mellitus comorbidity. · Chem Biol Interact · 2026-08-27
- An MLL-Independent Function of Menin Promotes Resistance to MAPK-Targeted Therapy · bioRxiv Cancer Biology · 2026-08-26
- TPD52 promotes breast cancer cell migration, invasion and proliferation via activation of the MAPK/ERK signaling pathway · medRxiv Oncology · 2026-08-10
- Stability of c-Myc protein differentiates Ras oncogene addiction and MAPK pathway dependency in Ras-mutant multiple myeloma · bioRxiv Cancer Biology · 2026-08-07
- BRAF V600E-Mutated Metastatic Colorectal Cancer: Practical Management in the Post-BREAKWATER Era. · J Gastrointest Cancer · 2026-08-31
- KRAS G12C-mutated Metastatic Colorectal Cancer: Current Therapeutic Strategies and Future Directions. · J Gastrointest Cancer · 2026-08-18
What the reporting says
It shows up alongside Colorectal Cancer (10), KRAS (8).
Two steps out: Braf (through Colorectal Cancer, 10 shared stories on the weaker link); Chen (through Colorectal Cancer, 10 shared stories on the weaker link); ctDNA (through Colorectal Cancer, 10 shared stories on the weaker link); Egfr (through Colorectal Cancer, 10 shared stories on the weaker link).
Tracked since Mar 15, with coverage on 18 separate days — concentrated in Oncology and Pubmed Targeted.